Analyst stock forecast
ALX Oncology Holdings Forecast: $4.60 Analyst Target
ALXO has a $4.60 target, Strong Buy rating and 5 analysts. As of 2026-08-24.
Direct answer
ALX Oncology Holdings's average price target is $4.60.
The target implies +125.5% from the recorded current price, and the consensus rating is Strong Buy.
The low target implies +96.1%, the high target implies +194.1%, and the range spans 98% of the current price.
Forecast evidence checked August 24, 2026.
Get free ALX Oncology Holdings email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $2.04
- Average price target
- $4.60
- High price target
- $6.00
- Low price target
- $4.00
- Low target gap
- +96.1%
- Target upside
- +125.5%
- High target gap
- +194.1%
- Target range width
- 98%
- Consensus rating
- Strong Buy
- Analysts
- 5
- Evidence date
- August 24, 2026
- Valid through
- August 31, 2026
Explore related company data
Read the frequently asked questions.
What is ALX Oncology Holdings's average price target?
ALX Oncology Holdings's verified average price target is $4.60. The target range is $4.00 to $6.00.
How far are ALX Oncology Holdings's low and high targets from the recorded price?
The low target implies +96.1%, while the high target implies +194.1%.
How many analysts are included in ALX Oncology Holdings's consensus?
The verified consensus includes 5 analysts.
How is ALX Oncology Holdings's target upside or downside calculated?
The average target of $4.60 is divided by the recorded price of $2.04, then one is subtracted to produce +125.5%. This does not guarantee a future return.
When was ALX Oncology Holdings's analyst forecast verified?
The data was verified on 2026-08-24. The dataset is valid through 2026-08-31.